Delirium in terminal cancer: a prospective study using daily screening, early diagnosis, and continuous monitoring.

摘要: Abstract A pilot prospective cohort study was conducted to determine delirium frequency and outcome in cancer patients consecutively hospitalized for terminal care (median stay: 12 days). Screening symptoms performed daily, using the Confusion Rating Scale. Patients positive on screening had a diagnostic assessment within 24 hours Assessment Method. Monitoring of continued until death. Eighteen (20%) 89 were at admission. Among 71 free admission, incidence confirmed 32.8% (95% CI, 21.3–44.3%). received higher mean equivalent parenteral daily dose morphine than other (72 mg vs. 41 mg, p = 0.08). Significant symptom improvement occurred 16 (50%) 32 delirious cases. Delirium is serious frequent complication whose may not be as poor previously considered.